The Compounding Pharmacy of America Recalls Recalls by year
A bar chart of the number of recalls naming this company by year.
Recalls by year
Year Recalls 2015 99 2018 1
Download CSV FDA Recall
Terminated
Historical record Class II
Hydromorphone 20 mg/ml + Bupivacaine 0.25 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Hydromorphone 10 mg/ml + Bupivacaine 10 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Hydromorphone 0.25 mg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Hyaluronidase 175 units/ml Injection, ml, Sterile, Preserved, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Hyaluronic Acid Sodium 35 mg/ml + Lidocaine HCl 3 mg/ml Injection, ml Syringe, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Hyaluronic Acid Sodium 32 mg/ml + Lidocaine HCl 3 mg/ml Injection, ml Syringe, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 500 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 5,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 3,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 1,100 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, 30 DAY KIT, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 1,500 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
HCG 5,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
This page lists recalls that name The Compounding Pharmacy of America as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer .
